BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19570996)

  • 1. The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease.
    Nagy N; Matskova L; Kis LL; Hellman U; Klein G; Klein E
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11966-71. PubMed ID: 19570996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The apoptosis modulating role of SAP (SLAM associated protein) contributes to the symptomatology of the X linked lymphoproliferative disease.
    Nagy N; Matskova L; Hellman U; Klein G; Klein E
    Cell Cycle; 2009 Oct; 8(19):3086-90. PubMed ID: 19738428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development.
    Nagy N; Klein E
    Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type p53 activates SAP expression in lymphoid cells.
    Nagy N; Takahara M; Nishikawa J; Bourdon JC; Kis LL; Klein G; Klein E
    Oncogene; 2004 Nov; 23(53):8563-70. PubMed ID: 15378026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
    Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
    Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.
    Sharifi R; Sinclair JC; Gilmour KC; Arkwright PD; Kinnon C; Thrasher AJ; Gaspar HB
    Blood; 2004 May; 103(10):3821-7. PubMed ID: 14726378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLAM-associated protein deficiency causes imbalanced early signal transduction and blocks downstream activation in T cells from X-linked lymphoproliferative disease patients.
    Sanzone S; Zeyda M; Saemann MD; Soncini M; Holter W; Fritsch G; Knapp W; Candotti F; Stulnig TM; Parolini O
    J Biol Chem; 2003 Aug; 278(32):29593-9. PubMed ID: 12766168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
    Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
    Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The X-linked lymphoproliferative disease gene product SAP associates with PAK-interacting exchange factor and participates in T cell activation.
    Gu C; Tangye SG; Sun X; Luo Y; Lin Z; Wu J
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14447-52. PubMed ID: 16983070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.
    Snow AL; Marsh RA; Krummey SM; Roehrs P; Young LR; Zhang K; van Hoff J; Dhar D; Nichols KE; Filipovich AH; Su HC; Bleesing JJ; Lenardo MJ
    J Clin Invest; 2009 Oct; 119(10):2976-89. PubMed ID: 19759517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The X-linked lymphoproliferative syndrome gene product SAP regulates B cell function through the FcgammaRIIB receptor.
    Li C; Chung B; Tao J; Iosef C; Aoukaty A; Wang Y; Tan R; Li SS
    Cell Signal; 2008 Nov; 20(11):1960-7. PubMed ID: 18662772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
    Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
    Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
    Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
    J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. II. receptor-mediated Akt/PKB and ERK1/2 activation and transcription factors expression profile.
    Shlapatska LM; Kovalevska LM; Gordiienko IM; Sidorenko SP
    Exp Oncol; 2014 Sep; 36(3):162-9. PubMed ID: 25265348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
    Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal T cell receptor signal transduction of CD4 Th cells in X-linked lymphoproliferative syndrome.
    Nakamura H; Zarycki J; Sullivan JL; Jung JU
    J Immunol; 2001 Sep; 167(5):2657-65. PubMed ID: 11509608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection.
    Talaat KR; Rothman JA; Cohen JI; Santi M; Choi JK; Guzman M; Zimmerman R; Nallasamy S; Brucker A; Quezado M; Pittaluga S; Patronas NJ; Klion AD; Nichols KE
    Pediatr Blood Cancer; 2009 Dec; 53(6):1120-3. PubMed ID: 19621458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease.
    Wu C; Sayos J; Wang N; Howie D; Coyle A; Terhorst C
    Immunogenetics; 2000 Aug; 51(10):805-15. PubMed ID: 10970095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.